CURRICULM VITAE Susie H. Park, Pharm.D., BCPP, FCSHP PERSONAL INFORMATION
Title:
Assistant Professor of Clinical Pharmacy and Pharmaceutical Economics and Policy
University of Southern California School of Pharmacy 1985 Zonal Avenue Los Angeles, CA 90033-0804
EDUCATION
1989-1993
University of California, San Diego La Jolla, California Bachelor of Arts Psychology (Cum Laude)
University of Southern California School of Pharmacy Los Angeles, California Doctor of Pharmacy
Psychiatric Pharmacy Practice Residency (ASHP-Accredited) University of Southern California School of Pharmacy Los Angeles, California
LICENSURE
2000 to present
State of California, Board of Pharmacy: Registered Pharmacist License Number RPH 52132; Expires 06-30-14
CREDENTIALS 1996
Compounding Pharmacy, Professional Compounding Center of America
Smoking Cessation Training, University of Pittsburgh
Emergency Contraception Program, Los Angeles Planned Parenthood
Board Certified Psychiatric Pharmacist (BCPP),
Board of Pharmaceutical Specialties; BPS No. 404005452; Recertification Completed in 2011
Certificate of Completion, Institutional Review Board Course, Los Angeles County + Children’s Hospital Los Angeles
Basic Life Support (CPR & AED), American Heart Association
Comprehensive Immunization Education and Training, American Pharmacists Association
ACADEMIC APPOINTMENTS 2004-Present
Assistant Professor Titus Family Department of Clinical Pharmacy and Pharmaceutical Economics and Policy University of Southern California School of Pharmacy Los Angeles, CA
Adjunct Assistant Professor Department of Pharmacy University of Southern California School of Pharmacy Los Angeles, CA
Lecturer and Clinical Preceptor of Clinical Pharmacy Practice University of Southern California School of Pharmacy Los Angeles, CA
PROFESSIONAL EXPERIENCE Time Position Location
GI/Hepatology Healthcare Consultation Center LAC-USC Hospital System Los Angeles, CA
Consultation Liaison Psychiatry Department of Psychiatry LAC-USC Hospital System Los Angeles, CA 90033
Kaiser Permanente Outpatient Pharmacy 4700 Sunset Boulevard Los Angeles, CA 90027
Adult Outpatient Psychiatry Clinic LAC-USC Healthcare System Los Angeles, CA 90033
Resident/Clinical Pharmacist Ingleside Inpatient Psychiatric Hospital
LAC-USC Hospital System Rosemead, CA 91770
Resident/Clinical Pharmacist Outpatient Dual Diagnosis Clinic
Veteran’s Affairs West Los Angeles Los Angeles, CA 90073
HIV Outpatient Clinic LAC-University of Southern California Los Angeles, CA 90033
USC Pharmacy at the Doheny Eye Institute 1450 San Pablo Street, Suite 2500 Los Angeles, CA 90033
Park Compounding Pharmacy 280 N Westlake Boulevard Suite 100 Westlake Village, CA 91362
Technician/Intern/Pharmacist Village Pharmacy
3137 S Hoover Street Los Angeles, CA 90007
Professional Service Projects
Time
Clozapine Monitoring Protocol LAC+USC Adult Outpatient Psychiatry Clinic
Protocol for the Use of Growth Factors in Interferon-Treated HCV patients LAC+USC Hepatology Clinic
Ambien Formulary Request Co-Authored and presented with Isabel Lagomasino, MD USC- Los Angeles County Department of Health Services
Wellbutrin XL Formulary Request Co-Authored with Jeffrey Uy, MD USC- Los Angeles County Department of Health Services
Clozapine Protocol 2002 Update Co-Authored with Julie Dopheide, Pharm.D. & Tim Botello, M.D Los Angeles County-USC Hospital Services Psychiatry Department
HONORS and AWARDS 2013
Recognition Award for Excellence in Teaching
University of Southern California Keck School of Medicine Psychiatric Residency Program Class of 2013
Professor of the Year Level Four University of Southern California School of Pharmacy
Psychiatric Care Outstanding Preceptor USC School of Pharmacy Residency Program
Practitioner Fellow California Society of Health-System Pharmacists (FCSHP)
Professor of the Year Level Four University of Southern California School of Pharmacy
Phi Lambda Sigma Leadership Mentoring Award USC School of Pharmacy
American Association of Colleges of Pharmacy Wal-Mart Annual Conference Scholarship for Mentor-Student
Professor of the Year Level Four University of Southern California School of Pharmacy
American College of Clinical Pharmacy New Investigator Award Sanofi-Aventis Central Nervous System Research Award
Professor of the Year Level Four University of Southern California School of Pharmacy
Professor of the Year Level Four University of Southern California School of Pharmacy
American Association of Colleges of Pharmacy Teacher of the Year
Honored Member Recognition Phi Lambda Sigma
Professor of the Year Level Four University of Southern California School of Pharmacy
Professor of the Year Level Four University of Southern California School of Pharmacy
Resident of the Year University of Southern California School of Pharmacy
Leadership in the Health Sciences Honor University of Southern California
Leadership in Pharmacy Leiner Health Products Award
Excellence Award for Drug Information Mylan Pharmaceuticals
Cum Laude University of California, San Diego
TEACHING
Pharm.D. Student Clinical Training Time Level of Teaching
Resident Training Psychiatry Pharmacy Practice Time Resident
PGY I General Pharmacy Practice Resident
PGY I General Pharmacy Practice Resident
PGY I General Pharmacy Practice Resident PGY II Psychiatric Pharmacy Resident
PGY I General Pharmacy Practice Resident PGY II Psychiatric Pharmacy Resident
PGY I General Pharmacy Practice Resident PGY II Psychiatric Pharmacy Resident
PGY I General Pharmacy Practice Resident PGY II Psychiatric Pharmacy Resident
PGY I General Pharmacy Practice Resident PGY II Psychiatric Pharmacy Resident
Pharmacy Practice and Primary Care Time Resident Student Research Training 2013
Managing sleep disturbance in HCV-infected patients treated with
Investigation in the use of antipsychotic polypharmacy in refractory
schizophrenic patients on clozapine therapy
A prospective, naturalistic cohort study on the use of antidepressants in
hepatitis C virus infected patients with interferon-induced depression
Didactic Teaching PharmD Curriculum Period Lecture Topics
Pharmacologic Treatment of Hepatitis C Virus
Clinical Research Data Collection and IRB
Laboratory Monitoring and Medical Records
Clinical Application of Pharmacogenomics
Pregnancy and Psychotropics Premenstrual Dysphoric Disorder Sexual Dysfunction in Women
Review of Anticonvulsants and Their Indications
New Drugs Chemical Stability & Pharmaceutical Dosage Forms Parkinson’s and Alzheimer’s Disease Agents Drugs and Pregnancy Antiemetics- Review of OTC & Rx Classes
Graduate and Post Program
Lecture Topics
Clinical Application of Pharmacogenomics Parts I & II
Pregnancy and Psychotropics Complementary and Alternative Medicines in Treating Psychiatric Disorders Current Issues in Psychiatry and Psychotropics Psychotropic Medication Updates Pharmacologic Issues of Treating Anxiety Management of Bipolar Disorders Antidepressant Medication Selection
Course Coordination
Therapeutics II (Pharmacogenomics and Introduction to Clinical Skills)
Therapeutics II (Pharmacogenomics) Course Co-Coordinator
Psychiatric Pharmacy Elective Co-Coordinator
USC School of Pharmacy Licensure Examination Review (LER) Sessions
California Korean Pharmacists Association Board Examination Review
COMMITTEE MEMBERSHIPS Period Positions Organization
Southern California Society of Health-Systems Pharmacists
Nominating Committee USC Alumni Association Executive Board
Admissions Committee USC School of Pharmacy
Recertification Editorial Board College of Psychiatric and Neurologic Pharmacists (CPNP)
Medication Monitoring Committee LAC+USC Adult Outpatient Psychiatry Clinic
Annual Student Scholarship Endowment Committee:
California Korean American Pharmacists Association (CKAPhA)
Continuing Pharmacy Education Committee CKAPhA
Abstract Selection California Society of Health-Systems Pharmacists (CSHP)
Value of a Psychiatric Pharmacist Committee ACCP/CPNP Task Force on White Paper
Executive Board Pharmacy Faculty Assembly USC School of Pharmacy
Executive Board Pharmacy Faculty Assembly USC School of Pharmacy
Intermodule Coordinating Council (IMCC) USC School of Pharmacy
Pharmacy Faculty Assembly USC School of Pharmacy
Recertification Committee College of Psychiatric and Neurologic Pharmacists
Executive Board Pharmacy Faculty Assembly USC School of Pharmacy
Advanced Pharmacy Practice Experience Committee USC Department of Clinical Pharmacy
Planning Committee for the Alumni and Friends Golf Outing USC School of Pharmacy
Strategic Planning For Faculty Development USC School of Pharmacy
USC Alumni Senior Awards Committee USC School of Pharmacy
Policy Committee California Pharmacists Association
OTHER PROFESSIONAL ACTIVITIES Editorial Boards 2010-Present
Current Topics in Parkinson’s Disease™
Drug Database for pregnancy and endocrine agents Drug Databases for pregnancy and cephalosporins
Journal Referee Journal of the American Pharmacists Association American Journal Health-System Pharmacy National Speakers Bureaus
Corporation
PROFESSIONAL AFFILIATIONS
2006
American Association of Colleges of Pharmacy
College of Psychiatric and Neurologic Pharmacists
California Korean American Pharmacists Association
American Society of Health-System Pharmacists
California Society of Health-System Pharmacists
AREAS OF RESEARCH INTEREST
Psychiatric aspects of hepatitis C virus infection
Pharmacogenomics of major depressive disorder Pharmacogenetics of schizophrenia
RESEARCH SUPPORT
2009-2012
Funding Agency: California Korean American Pharmacists
Title: Genetic markers for depression in a Korean population
Funding Agency: Titus School of Pharmacy Research Grant
Title: Pharmacogenetic markers for adherence in HIV patients
Title: Pharmacogenomics and pharmacokinetics of a method for
predicting renal insufficiency of tenofovir
Funding Agency: American College of Clinical Pharmacy
Sanofi-Aventis Central Nervous System Research Award
Title: Serotonin transporter gene polymorphisms in HCV patients
RESEARCH
Active Projects
1. Park S, Xie Y. Managing sleep disturbance in HCV-infected patients treated with interferon
2. Widner S, Virata R, Park S. Clozapine prescribing practices: a survey of prescribers’ use,
previous experiences, and knowledge of clozapine.
3. Park S, Brantman S. Antidepressant use in HCV-treated patients.
4. Park S, Song G. Polypharmacy of antipsychotics with clozapine in patients with psychotic
5. Park S, Lee A, Cho Y, Yum K, Chung M, Hwang Z. Incidence of influenza after influenza
6. Park S, Louie, Haubrich R, et al. Serotonin transporter linked promoter region (5-HTT-LPR)
polymorphism: a predictor of adherence with antiviral therapy genomics substudy.
Completed Scientific Projects
1. Park S, Bolger M, Dopheide J. Compatibility of risperidone solution and lithium citrate
syrup. Bench laboratory study conducted in the University of Southern California laboratories of Mark Gill, Pharm.D. (2000)
2. Liu C, Park S, Goad J. Depression and suicide in college students: early detection and
prevention service in a campus pharmacy. (2005)
3. Chung B, Park S. Medication utilization in fibromyalgia patient with depression.
Retrospective chart review of therapies used for treatment of co-morbid depression and fibromyalgia. (2007)
4. Park S, Fong T, Burckart G, Louie S. Serotonin transporter gene polymorphism in HCV
patients. Human Studies trial conducted at the Healthcare Consultation Center at University Hospital and the hepatology clinic at LA County Outpatient Clinic. (2007)
5. Wackernah R, Park S. The Impact of depression on the sustained viral response of interferon
treatment in patients with hepatitis C. (2011)
RESEARCH POSTER PRESENTATIONS
1. Park SH, Dopheide JA, Gill M. Compatibility of risperidone solution and lithium citrate syrup. 18th Annual Western States Conference for Pharmacy Residents, Fellows, and Preceptors. Pacific Grove, CA; May 2001.
2. Park SH. Psychiatric pharmacist intervention and consultation in a liver clinic. College of
Psychiatric and Neurologic Pharmacists 9th Annual Meeting in Baltimore, MD; April 2006.
3. Park SH, Burckart G, Fong T, Lagomasino I, Louie S. Serotonin transporter polymorphism in HCV patients: preliminary data. College of Psychiatric and Neurologic Pharmacists 9th Annual Meeting in Baltimore, MD; April 2006.
4. Liu C, Park SH, Goad J. Depression and suicide in college students: early detection and prevention service in a campus pharmacy. 22nd Annual Western States Conference for Pharmacy Residents, Fellows, and Preceptors. Pacific Grove, CA; May 2006.
5. Park SH. Consultation services by a psychiatric pharmacist in a liver clinic optimizes interferon treatment. California Society of Health-Systems Pharmacists Seminar 2006 in Sacramento, CA; October 2006.
6. Park SH. A psychiatric pharmacist in a liver clinic optimizes HCV treatment. Southern
California Society of Health-Systems Pharmacists Night with Industry Dinner in Marina del Rey, CA; January 2007.
7. Park SH, Burckart G, Fong T, Lagomasino I, Louie S. Serotonin transporter gene polymorphism in HCV patients. American College of Clinical Pharmacy Annual Meeting in Denver, CO; October 2007.
8. Chung B, Park SH. Medication utilization in fibromyalgia patients with depression: retrospective chart review of therapies used for treatment of co-morbid depression and fibromyalgia. 24th Annual Western States Conference for Pharmacy Residents, Fellows, and Preceptors. Pacific Grove, CA; May 2008.
9. Chung B, Park SH. Fibromyalgia and major depressive disorder: assessment of pain and depression control in an outpatient adult psychiatry clinic. College of Psychiatric and Neurologic Pharmacists Annual Meeting in Jacksonville, FL; April 2009.
10. Wackernah R, Park SH. The impact of depression on the sustained viral response of interferon treatment for hepatitis C. College of Psychiatric and Neurologic Pharmacists Annual Meeting in Phoenix, AZ; May 2011.
11. Hill-Besinque K, Durham M, Williams B, Chen S, Park S, Vanderveen RP.
Interprofessional education at the USC School of Pharmacy: lessons learned, barriers, and future trajectory. American Association of Colleges of Pharmacy Annual Meeting in Kissimmee, FL; July 2012. PUBLICATIONS Peer-Reviewed
1. Dopheide J, Park S. An update on the pharmacotherapy of anxiety disorders. CJHP; Jan/Feb
2. Dopheide J, Park S. Special report on anxiety disorders. Psychopharmacology of anxiety. Psychiatry Times; March 2002:37-48.
3. Park S, Dopheide J, Gill, M. The visual compatibility of risperidone solution and lithium
citrate syrup. AJHP March 2003;60(6):612-613.
4. Kim J, Phongsamran P, Park S. Use of antidepressant drugs in transplant recipients. Progress in Transplantation 2004;14(2):98-104.
5. Cohen S, Park S. Perimenopause and depression: treatment considerations. Calif Pharmacist
6. Kim J, Park S, Louie S. Telbivudine: A novel nucleoside analogue for chronic hepatitis B. Annals of Pharmacotherapy 2006;40:472-8. DOI 10.1345/aph.1G027
7. Khachatryan A, Park S. Impact of community pharmacists on mental health. Calif
8. Chung B, Park SH. Fibromyalgia and major depressive disorder: assessment of pain and
depression control in an outpatient adult psychiatry clinic. J Pharm Pract 2009;22:214-5.
9. Wackernah RC, Park SH. The impact of depression on the sustained viral response of
interferon treatment with hepatitis C. J Pharm Pract 2011;24:279-80.
10. Wackernah R, Lou, M, Park SH. Retrospective chart review to assess the relationship
between depression and sustained virological response from interferon treatment for hepatitis C virus. Clinical Therapeutics 2011;33(10):1400-5.
11. Park SH, Kim JW. Use of atypical antipsychotics in the elderly. California Pharmacist
12. Park SH, Khorsandi P. Pharmacologic treatment options for major depressive disorder. California Pharmacist 2011;58(4):29-35.
13. Park SH. Completion of chronic hepatitis C virus treatment in interferon-induced major
depressive disorder with psychotic features. Psychiatry Investig 2011;8:381-83.
14. Park S, Ishino R. Liver injury associated with antidepressants. Current Drug Safety Other Professional Publications
15. Park S, Cupo Abbott J, and Gill MA. The role of second-generation antihistamines in allergic
rhinitis. California Pharmacist Insights 2000;12 (July 15, no 13):9-18.
16. Park S. Case study of hepatitis C and depression. Science Press Internet Services Limited;
London, UK; 07-09-04. http://www.psychiatrysource.com/psychsource/Case_Studies/article693.htm
17. Park S. The role of benzodiazepines in bipolar disorder treatment. Science Press Internet
Services Limited; London, UK; 10-26-05. http://www.psychiatrysource.com/35897_36132_0_0_0.aspx 2006.
18. Park S. Pharmacotherapy of anxiety disorders: focus on generalized anxiety disorder and
panic disorder. California Korean American Pharmacists Association Newsletter 2008;20(3): 7-9.
Book Chapters
1. Park S, Louie S. Principles of Immunology. In: Remington’s Pharmaceutical Sciences 21st
ed. Lippincott, Williams & Wilkins: Philadelphia, 2005: Chapter 60.
2. Park SH. Bipolar Disorders. In: McGraw Hill’s NAPLEX Review Guide 1st ed. McGraw Hill
3. Park S, Louie S. Principles of Immunology. In: Remington: The Science and Practice of Pharmacy 22nd ed. Pharmaceutical Press; Philadelphia, 2013: Chapter 56.
Accepted Manuscripts in Press
1. Park S, Wackernah R, Stimmel G. Serotonin syndrome with tramadol and serotonergic
antidepressants- what’s the concern? Journal of Pharmacy Practice.
2. Park S, Han L, Lee A, Lee J, Lieu S. Catching your Zzzzs, or not, with the non-
benzodiazepine hypnotics: concerns about their safety. California Korean American Pharmacists Association Newsletter.
3. Park S. Off-label use of atypical antipsychotics: lack of evidence for their use in primary
4. Nazarian, PK, Park S. Antidepressant Management of Insomnia Disorder in the Absence of a
Mood Disorder. Mental Health Clinician. Manuscript in Review
Park, S. The psychiatric pharmacist managing hepatitis C virus infection. Mental Health Clinician. Manuscripts in Preparation
1. Park SH, Burckart G, Fong, Chan L, Louie S. Serotonin transporter polymorphism in HCV
2. Louie S, Goicoechea M, Park S, Haubrich R. Genetic polymorphism as a predictor of
3. Park S. Review of interferon-associated psychosis and its management.
4. Park S. Clozapine use during pregnancy: a review of the literature.
5. Park S. Use of antidepressants in HCV-infected patients for managing psychiatric side effects.
6. Wackernah R, Park S. Hepatotoxicity of antipsychotics.
INVITED LECTURES
Regional Conferences and Continuing Education Against Reciprocity and the Manpower Shortage in California California State Board of Pharmacy Manpower Shortage Open Forum Sacramento, CA; September 1999
Alternative Careers in Pharmacy: A New Practitioner Roundtable California Pharmacists Association (CPhA) Western Educational Faire Sacramento, CA; September 2002
Update on the Use of Antidepressant Medications California Society of Health-System Pharmacists (CSHP) Seminar 2002 Anaheim, CA; October 2002
Top 10 New Drugs for 2003 29th Annual Review: USC Department of Family Medicine Keck School of Medicine Los Angeles, CA; February 2003 Common Problems in Primary Care- 2004 30th Annual Review: USC Department of Family Medicine Keck School of Medicine Los Angeles, CA; February 2004
Dyslipidemia: An Update on the Use of Statins Education Program Series California Korean American Pharmacists Association Los Angeles, CA; February 2004
Atypical Antipsychotics: Issues for the Next Generation Spring Continuing Education Series University of Southern California Alumni Association Los Angeles, CA; June 2005
Atypical Antipsychotics: Updates for the Pharmacist Continuing Education Program California Pharmacists Association Hollywood-Wilshire Division Los Angeles, CA; May 2006
A Case Study of Depression in a Hepatitis C-Infected Patient: Hepatitis C and Major Depressive Disorder Chinese University of Hong Kong Visiting Student Program Los Angeles, CA; June 2006 Emsam- the First Antidepressant Patch Bristol Myer’s Squibb Program Los Angeles & S. Pasadena, CA; July 2006-December 2009 The Next Generation of Atypical Antipsychotics Agents: Are They the Same? Continuing Education Program Orange County Pharmacists Association Orange, CA; May 2007 Preparing for the NAPLEX and CPJE Examinations California Society of Health-System Pharmacists Seminar 2007 Palm Springs, CA; October 2007 Conflict Resolution for Pharmacy Students California Pharmacists Association Student Summit San Diego, CA; April 2008
Investigation into Managed Care and Psychiatry Western Managed Care Student Program USC Orange County Center Facility; Irvine, CA; June 2009
Pharmacological Management of Major Depression in the Primary Care Setting Primary Care Residents Conference Presbyterian Intercommunity Hospital Family Practice Whittier, CA; July 2009 Treatments for Hepatitis C and HIV Co-Infection Roche Program Los Angeles, CA; January 2009-December 2010 Use of Atypical Antipsychotics for Bipolar Disorder Pfizer Program Los Angeles and Pasadena, CA; December 2009-January 2011
Atypical Antipsychotics: an Update and Discussion of Their Atypical Uses California Society of Health-System Pharmacists Seminar 2011 Anaheim, CA; November 2011 Sexual Dysfunction in Men and Women: Pillow Talk (or Not) Getaway Seminars, Incorporated; Continuing Pharmacy Education seminar San Diego, CA; May 2013
California Society of Health-System Pharmacists Seminar 2013 Anaheim, CA; November 2, 2013
Grand Rounds
Profiling Clozapine: A Review and Update Grand Rounds Lecture at University of Southern California Health Sciences Campus USC Department of Psychiatry, Keck School of Medicine; Los Angeles, CA; March 2004 The Risks of Smoking in Schizophrenia: Is it All Smoke? Grand Rounds Lecture at University of Southern California Health Sciences Campus USC Department of Psychiatry, Keck School of Medicine; Los Angeles, CA; April 2008
Case of a Pregnant Patient with a History of Bipolar Disorder: The Decision to Breastfeed or Not. Grand Rounds Lecture at University of Southern California Health Sciences Campus, USC Department of Psychiatry, Keck School of Medicine; Los Angeles, CA; February 2010
Atypical Antipsychotics in Pregnancy: Do We Know Much More? Grand Rounds Lecture at University of Southern California, Health Sciences Campus USC Department of Psychiatry, Keck School of Medicine; Los Angeles, CA; April 2011 National/International
Something New About Old Drugs: A Discussion on Drug Dosage Form Delivery California Korean Pharmacists Association 8th Annual Symposium 2003, Las Vegas, NV July 25, 2003
Advanced Pharmacy Practice Experiences- Psychiatric Pharmacy Practice Meijo University 1st Annual International Clinical Pharmacy Education Symposium and Workshop; Nagoya, Japan: Special Lecturer February 26, 2005 Pharmacogenomics for the Pharmacist Continuing Education Program Korean American Pharmacists Association U.S.A. 10th Annual Symposium of Korean Pharmacists; Seoul, Korea October 17, 2005 Translational Research in Psychiatry Korean-American Scientists and Engineers Association 17th Annual Technology Conference, Pasadena, CA February 10, 2007
Utilizing Your Psychiatric Pharmacist in the Community Setting National Alliance on Mental Illness Annual Conference; San Diego, CA June 22, 2007
Atypical Antipsychotics: Do the Growing Indications Make Sense? Continuing Education Program Korean American Pharmacists Association of the USA 16th Annual Symposium; New York, NY October 2, 2011 Management of Bipolar Disorders Pre-Meeting Workshop on Update on Psychotropics: New Agents and Guidelines Panel Symposium American College of Clinical Pharmacology (ACCP) Annual Meeting; San Diego, CA September 22, 2012 Safety of SSRI Use During Pregnancy- Who has the Final Word? Late-Breakers American College of Clinical Pharmacy (ACCP) Annual Meeting; Albuquerque, New Mexico October 15, 2013
SEMINARS AND OTHER LECTURES August 2000
Adjunctive Treatments to Lithium for Bipolar Disorder
The Use of Psychotropic Medications in the Elderly
Depakote Drug Interactions in the Psychiatry Ward
Psychopharmacology of Benzodiazepine-1-Selective Hypnotics
Pharmacotherapy of Psychotropics- A Review
A Review of Antidepressants and Mood Stabilizers
Agents Used for the Treatment of Schizophrenia
Pharmacological Treatment Options for Major Depression: Comparison of Agents
Selecting an Antidepressant: Medical Comorbidity Considerations
The Use of Psychotropic Agents in Psychiatric Practice- What Psychologists Need to Know
From Molecules to the Mind: Psychopharmacogenomics
Medications Used for the Treatment of Alzheimer’s Disease: Comparing the Two Classes of Agents
Agents Used for Headaches: the Anticonvulsants
Second Generation Antipsychotics and QTc Prolongation
Gender Differences in Psychiatric Disorders
Psychiatric Disorders During and After Pregnancy
Premenstrual Syndrome and Premenstrual Dysphoric Disorder
IV Haloperidol for Acute Agitation: Less EPS than Oral Haloperidol
Depression Among the Homeless: SHARE Project
Pipeline Review: Medications for Depression, Schizophrenia, Bipolar Disorder, Anxiety and Sleep Disorders
Psychotropic Medication Use in Pregnancy and Lactation
Professionalism and Leadership Among Pharmacy Student Body
Clinically Significant Drug Interactions
An Investigation and Evaluation of Medication Misuse: Our Tribute to Michael Jackson
Emergency Medications for Acute Agitation/Psychosis
Tuberculosis Treatment in Patients with Psychiatric Conditions
Complementary and Alternative Medicines in Psychiatry: Focus on Depression
Tramadol: Painless Information on an Analgesic
Psychiatric Issues Related to Systemic Lupus Erythematosus (SLE)
Clinical Applications of Pharmacogenomics
Principles and Concepts of Pharmacogenetics
Therapeutics of Hepatitis C Virus Infection
Women and Pharmacy Careers: Balancing the Personal and Professional
Pharmacologic Treatment Options for Bipolar Disorder- an Update
Review of Psychotropics: A Focus on Antipsychotics and Mood Stabilizers-
QTc Prolongation of the Newer Atypical Antipsychotics
Triptans and MAOI Drug Interactions- a Few Contraindications
Pharmacogenomics of Drug Metabolism and Drug Interactions
The New Atypical Antipsychotics: Their Place in Current Therapy
Tardive Dyskinesia (TD) and Anticholinergics
A Review of Antipsychotic Medication-Induced QT Prolongation
Switching to Long-Acting Injectable Antipsychotics
Web-Based Education
Pharmacogenomics of CNS Drugs ACCP and FDA Pharmacogenomics Online CourseMarch 2007.
UNIVERSITY SERVICE/AFFILIATIONS
2012-2014
USC School of Pharmacy Admissions Committee
Medical and Pharmacy Student Collaboration (MAPSC)
Intermodule Coordinating Council Committee
Academy of Managed Care Pharmacy Drug Formulary Competition
USC Alumni Association Board of Directors
Academy of Students of Pharmacy Patient Counseling Competition,
American Society of Health-System Pharmacists Clinical Skills Competition
Korean American Pharmacy Student Association
COMMUNITY SERVICE
2013
Spring Health Faire at the Olympic Community Police Station supervisor
Global Leadership Development Institute, speaker representing pharmacy
profession to young adults Weingart Mental Health education
Wise Place supporter; organization that offers housing and support service for homeless women who are committed to changing their lives
Korean American Student Pharmacy Association Annual Health Faire: Immunization Supervisor and Health Fair Coordinator
Vietnamese American Pharmacy Student Association Health Faire
Legislative Day Health Fair: Mental Health Screening
Southland Pre-Health Conference: Connecting the Pieces: Building a Healthier Tomorrow Together; Pharmacist Panel; University of Southern California University Park Campus
Manhattan Beach Middle School Career Week
Korean American Student Pharmacy Association Health Faire Screening for diabetes and hypertension; primary vaccinations preceptor
Medication education support groups at LAC+USC Day Rehabilitation
USC School of Pharmacy Kid’s Day: Children’s Health Education
Fred Jordan Mission: Feeding the Homeless & Hygiene Kits
Korean Pharmacy Association Health Faire: Disease State Monitoring
Los Angeles Free Clinic: Patient Counseling
DOXYCYCLINE NOTICE BIOTOX La doxycycline est le produit actif contenu dans ce médicament. Ce médicament est un antibiotique de la famille des cyclines qui bénéficie d’une autorisation de mise sur la marché en France. Il est indiqué habituellement dans le traitement de certaines infections à germes sensibles à la doxycycline dans leurs manifestations respiratoires, génitales, ur
Safety data sheet According to Regulatin 1907/2006/EC, Article 31 and Regulation 1272/2008/EC 1 Identification of the substance / mixture and of the company / undertaking · Product identifier · Trade name: Impregnator for wood "AQUA" · Relevant identified uses of the substance or mixture and uses advised against · Application of the substance / the prepar